On July 1, 2025, MORL is furthering its commitment to advanced diagnostics with the launch of the PHASE Program. This initiative provides no-cost segregation testing for patients with autosomal-recessive hearing loss (LP/P variants) who have previously undergone OtoSCOPE® testing, ensuring more precise genetic diagnoses.
